It is known that the two most well studies proinflammatory pathways in IBD-CRC, NF-κB and IL-6/STAT3 signaling pathways, are dysregulated and thus promote IBD-CRC progression (79). This evidence concerns the gene IL6 and colorectal carcinoma.